Atherosclerosis
Volume 192, Issue 2 , Pages 253-258 , June 2007

Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: An in vitro model of the niacin flush

  • C. Daniel Meyers

      Affiliations

    • Long Beach Veterans Affairs Healthcare System, Long Beach, CA, United States
    • Corresponding Author InformationCorrespondence to: Novartis Institute for BioMedical Research, 400 Technology Square, Bldg 605/843, Cambridge, MA 02139, United States. Tel.: +1 617 871 4161; fax: +1 617 871 4091.
    • ,
  • Paul Liu

      Affiliations

    • Department of Internal Medicine, University of California, Irvine, CA, United States
    • ,
  • Vaijinath S. Kamanna

      Affiliations

    • Long Beach Veterans Affairs Healthcare System, Long Beach, CA, United States
    • Department of Internal Medicine, University of California, Irvine, CA, United States
    • ,
  • Moti L. Kashyap

      Affiliations

    • Long Beach Veterans Affairs Healthcare System, Long Beach, CA, United States
    • Department of Internal Medicine, University of California, Irvine, CA, United States

Received 7 December 2005 ,Revised 12 June 2006 ,Accepted 7 July 2006.

References 

  1. Altschul R, Hoffer A, Stephen JD. Influence of nicotinic acid on serum cholesterol in man. Arch Biochem. 1955;54:558–559
  2. Meyers CD, Kamanna VS, Kashyap ML. Niacin therapy in atherosclerosis. Curr Opin Lipidol. 2004;15:659–665
  3. Canner PL, Berge KG, Wenger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 1986;8:1245–1255
  4. Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583–1592
  5. Meyers CD, Carr MC, Park S, Brunzell JD. Varying cost and free nicotinic acid content in over-the-counter niacin preparations for dyslipidemia. Ann Intern Med. 2003;139:996–1002
  6. Stern RH, Spence JD, Freeman DJ, Parbtani A. Tolerance to nicotinic acid flushing. Clin Pharmacol Ther. 1991;50:66–70
  7. Gray DR, Morgan T, Chretien SD, Kashyap ML. Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans. Ann Intern Med. 1994;121:252–258
  8. Morrow JD, Parsons WG, Roberts LJ. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins. 1989;38:263–274
  9. Morrow JD, Awad JA, Oates JA, Roberts LJ. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol. 1992;98:812–815
  10. Urade Y, Ujihara M, Horiguchi Y, Ikai K, Hayaishi O. The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. J Immunol. 1989;143:2982–2989
  11. Boie Y, Sawyer N, Slipetz DM, Metters KM, Abramovitz M. Molecular cloning and characterization of the human prostanoid DP receptor. J Biol Chem. 1995;270:18910–18916
  12. Cheng K, Wu TJ, Wu KK, et al. Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. Proc Natl Acad Sci USA. 2006;103:6682–6687
  13. Schwende H, Fitzke E, Ambs P, Dieter P. Formation of eicosanoids during differentiation of THP-1 cells. Adv Exp Med Biol. 1997;407:491–495
  14. Faust D, Akoglu B, Faust AC, Milovic V. Human peritoneal macrophages in culture: a model for studying inflammatory disorders in vitro. Clin Exp Med. 2003;3:15–19
  15. Stern RH, Freeman D, Spence JD. Differences in metabolism of time-release and unmodified nicotinic acid: explanation of the differences in hypolipidemic action?. Metabolism. 1992;41:879–881
  16. Barrios-Rodiles M, Keller K, Belley A, Chadee K. Nonsteroidal antiinflammatory drugs inhibit cyclooxygenase-2 enzyme activity but not mRNA expression in human macrophages. Biochem Biophys Res Commun. 1996;225:896–900
  17. Jungnickel PW, Maloley PA, Vander Tuin EL, Peddicord TE, Campbell JR. Effect of two aspirin pretreatment regimens on niacin-induced cutaneous reactions. J Gen Intern Med. 1997;12:591–596
  18. Rubic T, Trottmann M, Lorenz RL. Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin. Biochem Pharmacol. 2004;67:411–419
  19. Powell WS. 15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product?. J Clin Invest. 2003;112:828–830
  20. Knowles HJ, Te Poole R, Workman P, Harris AL. Niacin induces PPARgamma expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways. Biochem Pharmacol. 2006;71:646–656
  21. Tang Y, Zhou L, Gunnet JW, Wines PG, Cryan EV, Demarest KT. Enhancement of arachidonic acid signaling pathway by nicotinic acid receptor HM74A. Biochem Biophys Res Commun. 2006;
  22. Benyo Z, Gille A, Kero J, et al. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest. 2005;115:3634–3640
  23. Dupasquier M, Stoitzner P, van Oudenaren A, Romani N, Leenen PJ. Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis. J Invest Dermatol. 2004;123:876–879
  24. Meunier L, Gonzalez-Ramos A, Cooper KD. Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells. J Immunol. 1993;158:4067–4080
  25. Havel RJ, Carlson LA, Ekelund LG, Holmgren A. Studies on the relation between mobilization of free fatty acids and energy metabolism in man: effects of norepinephrine and nicotinic acid. Metabolism. 1964;13:1402–1412

☆ Presented, in part at the western meetings of the American Federation for Medical Research in Carmel California, 2/2005 and the International Eicosinoid Conference in San Francisco, CA 9/2005.

PII: S0021-9150(06)00412-6

doi: 10.1016/j.atherosclerosis.2006.07.014

Atherosclerosis
Volume 192, Issue 2 , Pages 253-258 , June 2007

Article Tools

* Image Usage & Resolution